Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Disparity in Intestine Disposition between Formed and Preformed Metabolites and Implications: A Theoretical Study

Huadong Sun and K. Sandy Pang
Drug Metabolism and Disposition January 2009, 37 (1) 187-202; DOI: https://doi.org/10.1124/dmd.108.022483
Huadong Sun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Sandy Pang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Metabolite in safety testing has been proposed for toxicity assessments. The question of how exposure of the synthetic metabolite compared with that of the formed metabolite was appraised kinetically by using physiologically based pharmacokinetic models, the (traditional) physiological model (TM), and segregated flow (SFM) models. The SFM differs from the TM and describes a partial (∼10% total) intestinal flow that perfuses the absorptive, metabolic, and secretory enterocyte layer to account for the higher extent of metabolism observed with oral versus systemic dosing of drugs. Theoretical solutions for the areas under the curve (AUC) of the formed metabolite after oral and intravenous administration of the precursor (AUC{mi,P}) and preformed, synthetic metabolite (AUC{pmi}) showed identical AUCiv{mi,P}, AUCpo{mi,P}, and AUCpo{pmi} for both the TM and SFM, whereas a larger AUCiv{pmi} existed for the SFM. The AUC{pmi} was influenced by metabolite parameters only: binding, absorptive (ka{mi}) and luminal degradation (kg{mi}) constants, intrinsic clearances for metabolism (CLint,met,I{mi}), apical efflux (CLint,sec,I{mi}), and basolateral transfer (CLd1{mi} and CLd2{mi}) for the metabolite. By contrast, the AUC{mi,P} was influenced additionally by precursor parameters: rate constants ka and kg, and CLint,met,I and CLint,sec,I, but not the basolateral transfer clearances. The drug parameters: CLint,met,I and ka increased whereas CLint,sec,I decreased AUC{mi,P}, and the effect of secretion was counterbalanced by reabsorption with high ka values. The simulated time courses for the metabolites and the AUC{pmi} and AUC{mi,P} resulting from intravenous and oral routes of administration of preformed metabolite and precursor differed, inferring that the kinetics of the preformed and formed metabolites are not identical.

Footnotes

  • This work was supported by the Canadian Institutes for Health Research [Grant MOP89850].

  • Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.

  • doi:10.1124/dmd.108.022483.

  • ABBREVIATIONS: AUC, area under the concentration-time curve; {mi,P}, metabolite formed from precursor; {pmi}, preformed metabolite; PBPK, physiologically based pharmacokinetic model; TM, traditional model; SFM, segregated flow model; QI, blood flow for the whole intestine; P, precursor; CLd1 and CLd2, basolateral, transfer intrinsic clearances between blood and tissue for the TM, or between blood and the enterocytes layer for the SFM; CLint,met,I, metabolic intrinsic clearance of precursor; CLint,sec,I, secretory intrinsic clearance of precursor at the apical membrane; ka, rate constant of absorption for precursor; kg, rate constant of luminal transit and degradation; Fabs, fraction of drug absorbed from the intestinal lumen into intestine tissue; Qen, blood flow for the enterocyte layer; Qs, blood flow for the serosal layer; CLd3 and CLd4, transfer intrinsic clearances between serosal blood and serosal tissue; {mi}, qualifier for metabolite (formed and preformed); F{pmi}, the bioavailability of the preformed metabolite.

    • Received May 25, 2008.
    • Accepted October 20, 2008.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (1)
Drug Metabolism and Disposition
Vol. 37, Issue 1
1 Jan 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Disparity in Intestine Disposition between Formed and Preformed Metabolites and Implications: A Theoretical Study
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Disparity in Intestine Disposition between Formed and Preformed Metabolites and Implications: A Theoretical Study

Huadong Sun and K. Sandy Pang
Drug Metabolism and Disposition January 1, 2009, 37 (1) 187-202; DOI: https://doi.org/10.1124/dmd.108.022483

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Disparity in Intestine Disposition between Formed and Preformed Metabolites and Implications: A Theoretical Study

Huadong Sun and K. Sandy Pang
Drug Metabolism and Disposition January 1, 2009, 37 (1) 187-202; DOI: https://doi.org/10.1124/dmd.108.022483
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Appendix
    • I. TM: Preformed Metabolite
    • II. TM: Formed Metabolite
    • III. SFM: Preformed Metabolite
    • IV. SFM: Formed Metabolite
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Determination of Acyl-, O-, and N-Glucuronide
  • TMDD Affects PK of IL-10 Fc-fusion Proteins
  • Uptake as the RDS in Pevonedistat Hepatic Clearance
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics